AG10 Inhibits Amyloidogenesis and Cellular Toxicity of the Familial Amyloid Cardiomyopathy-Associated V122I Transthyretin

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1300761110
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Transthyretin-Associated Familial Amyloid Polyneuropathy - Current and Emerging Therapies

European Neurological Review
Neurology
2012English

Native State Stabilization by NSAIDs Inhibits Transthyretin Amyloidogenesis From the Most Common Familial Disease Variants

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2004English

Transthyretin Glu18, a New Variant Associated With Familial Amyloid Polyneuropathy

Journal of the University of Malaya Medical Centre
Medicine
1998English

Psy87 - Economic Burden of Transthyretin Familial Amyloid Polyneuropathy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Zinc Inhibits Human Islet Amyloid Polypeptide (IAPP) Amyloidogenesis

Biophysical Journal
Biophysics
2010English

The V122I Mutation in Hereditary Transthyretin-Mediated Amyloidosis Is Significantly Associated With Polyneuropathy

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Targeted Therapeutics for Transthyretin Amyloid Cardiomyopathy: Time to Move Forward

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Transthyretin Familial Amyloid Polyneuropathy Impact on Health-Related Quality of Life

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2015English

Estimating Population-Level Prevalence of Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy